Table 3.
Logistic regression analysis for factors associated with osteoporosis in the whole population of 211 patients with CP
| Univariatea | Multivariatea | |||
|---|---|---|---|---|
| OR (95% CI) | P-value | OR (95% CI) | P-value | |
| Age (per increasing year) | 1.06 (1.03–1.10) | 0.0002 | 1.07 (1.02–1.11) | 0.001 |
| Female sex | 3.44 (1.70–6.96) | 0.0005 | 2.78 (1.16–6.68) | 0.021 |
| BMI (per increasing unit) | 0.84 (0.76–0.94) | 0.001 | 0.84 (0.74–0.95) | 0.006 |
| PTH (per increasing unit) | 1.01 (1.00–1.01) | 0.01 | 1.01 (1.00–1.03) | 0.037 |
| Vitamin D deficiency | 1.10 (0.53–2.27) | 0.20 | – | |
| Vitamin K deficiency | 1.45 (0.64–3.29) | 0.18 | – | |
| CRP (per unit) | 0.98 (0.88–1.08) | 0.70 | – | |
| Faecal elastase (per increasing unit) | 1.00 (0.99–1.00) | 0.90 | – | |
| Diabetes | 0.81 (0.40–1.63) | 0.66 | – | |
| Active smoking | 1.10 (0.54–2.23) | 0.77 | – | |
| Advanced-marked disease | 0.47 (0.14–1.59) | 0.22 | – | |
| Alcholic aetiology | 0.82 (0.41–1.60) | 0.56 | – | |
| Disease duration (per year) | 1.00 (0.99–1.00) | 0.18 | – | |
| PERT | 1.01 (0.52–1.97) | 0.96 | – | |
BMI body mass index, PTH parathormone, CRP C-reactive protein, PERT pancreatic enzyme replacement therapy
aAdjusted for centre of enrolment